{"entity":{"type":"insider","cik":"0001504443","url":"/insider/0001504443","json_url":"/insider/0001504443.json","name":"Morris Ronnie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2013-01-30","last":"2023-03-21","span_basis":"filed_date"},"name_variants":[{"name":"Morris Ronnie","source":"filing","n_filings":15,"first_seen":"2013-01-30","last_seen":"2023-03-21"}],"transactions":[{"id":8306104,"accession":"0001628280-23-008699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-008699","line_url":"/filing/0001628280-23-008699#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12382.0,"shares_display":"12,382","price_per_share":4.0356,"price_display":"4.04","price_state":"stated","total_value":49968.7992,"total_display":"49,968.80","total_whole":"49,969","shares_owned_after":858878.0,"shares_owned_after_display":"858,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":2593643,"accession":"0001628280-20-004085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-004085","line_url":"/filing/0001628280-20-004085#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":393.75,"total_display":"393.75","total_whole":"394","shares_owned_after":837168.0,"shares_owned_after_display":"837,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-26","scope":"insider"},{"id":2273383,"accession":"0001628280-20-003966","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-20-003966","line_url":"/filing/0001628280-20-003966#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75.0,"shares_display":"75","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":356.25,"total_display":"356.25","total_whole":"356","shares_owned_after":837243.0,"shares_owned_after_display":"837,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-20","filed_date":"2020-03-24","scope":"insider"},{"id":6247142,"accession":"0001628280-18-015324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-18-015324","line_url":"/filing/0001628280-18-015324#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":7.44,"price_display":"7.44","price_state":"stated","total_value":148800.0,"total_display":"148,800.00","total_whole":"148,800","shares_owned_after":833001.0,"shares_owned_after_display":"833,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2018-12-20","scope":"insider"},{"id":6740929,"accession":"0001628280-18-003737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-18-003737","line_url":"/filing/0001628280-18-003737#line-2","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":3.617,"price_display":"3.62","price_state":"stated","total_value":8319.1,"total_display":"8,319.10","total_whole":"8,319","shares_owned_after":1116582.0,"shares_owned_after_display":"1,116,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-27","filed_date":"2018-03-28","scope":"insider"},{"id":6740926,"accession":"0001628280-18-003737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-18-003737","line_url":"/filing/0001628280-18-003737#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2235.0,"shares_display":"2,235","price_per_share":3.57,"price_display":"3.57","price_state":"stated","total_value":7978.95,"total_display":"7,978.95","total_whole":"7,979","shares_owned_after":1114282.0,"shares_owned_after_display":"1,114,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-26","filed_date":"2018-03-28","scope":"insider"},{"id":6882517,"accession":"0001628280-18-003566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-18-003566","line_url":"/filing/0001628280-18-003566#line-3","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440.0,"shares_display":"440","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":1540.0,"total_display":"1,540.00","total_whole":"1,540","shares_owned_after":1111847.0,"shares_owned_after_display":"1,111,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-26","scope":"insider"},{"id":6882514,"accession":"0001628280-18-003566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-18-003566","line_url":"/filing/0001628280-18-003566","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":260.0,"shares_display":"260","price_per_share":3.4865384615384616,"price_display":"3.49","price_state":"stated","total_value":906.5,"total_display":"906.50","total_whole":"907","shares_owned_after":1112047.0,"shares_owned_after_display":"1,112,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-26","scope":"insider","n_lines":2},{"id":2922031,"accession":"0001628280-16-020189","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-16-020189","line_url":"/filing/0001628280-16-020189","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.6633333333333333,"price_display":"1.66","price_state":"stated","total_value":49900.0,"total_display":"49,900.00","total_whole":"49,900","shares_owned_after":1111347.0,"shares_owned_after_display":"1,111,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-21","filed_date":"2016-10-24","scope":"insider","n_lines":3},{"id":2296633,"accession":"0001628280-16-020147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-16-020147","line_url":"/filing/0001628280-16-020147#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":1081347.0,"shares_owned_after_display":"1,081,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-19","filed_date":"2016-10-20","scope":"insider"},{"id":2191120,"accession":"0001628280-16-020090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-16-020090","line_url":"/filing/0001628280-16-020090","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10305.0,"shares_display":"10,305","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":17106.3,"total_display":"17,106.30","total_whole":"17,106","shares_owned_after":1071347.0,"shares_owned_after_display":"1,071,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-14","filed_date":"2016-10-17","scope":"insider","n_lines":2},{"id":2411135,"accession":"0001628280-16-020069","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-16-020069","line_url":"/filing/0001628280-16-020069","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29695.0,"shares_display":"29,695","price_per_share":1.66673514059606,"price_display":"1.67","price_state":"stated","total_value":49493.7,"total_display":"49,493.70","total_whole":"49,494","shares_owned_after":1041347.0,"shares_owned_after_display":"1,041,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-13","filed_date":"2016-10-14","scope":"insider","n_lines":4},{"id":2754916,"accession":"0001628280-16-020006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-16-020006","line_url":"/filing/0001628280-16-020006","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9537.0,"shares_display":"9,537","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":15831.42,"total_display":"15,831.42","total_whole":"15,831","shares_owned_after":1031347.0,"shares_owned_after_display":"1,031,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-10","filed_date":"2016-10-11","scope":"insider","n_lines":2},{"id":2359818,"accession":"0001628280-16-019676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-16-019676","line_url":"/filing/0001628280-16-019676#line-1","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":4740.0,"total_display":"4,740.00","total_whole":"4,740","shares_owned_after":1021810.0,"shares_owned_after_display":"1,021,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider"},{"id":8527372,"accession":"0001144204-15-016742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-016742","line_url":"/filing/0001144204-15-016742#line-2","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2710526.0,"shares_display":"2,710,526","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":3572174.0,"shares_owned_after_display":"3,572,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-17","scope":"insider"},{"id":6740125,"accession":"0001144204-14-017056","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-017056","line_url":"/filing/0001144204-14-017056","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.0699,"price_display":"1.07","price_state":"stated","total_value":106990.0,"total_display":"106,990.00","total_whole":"106,990","shares_owned_after":911648.0,"shares_owned_after_display":"911,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-21","scope":"insider","n_lines":3},{"id":4811756,"accession":"0001144204-13-004840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-13-004840","line_url":"/filing/0001144204-13-004840#line-2","is_derivative":false,"issuer_cik":"0000771856","issuer_name":"CHAMPIONS ONCOLOGY, INC.","issuer_ticker":"CSBR","issuer_name_source":null,"issuer_url":"/issuer/0000771856","owner_cik":"0001504443","owner_name":"Morris Ronnie","owner_display_name":"Morris Ronnie","owner_url":"/insider/0001504443","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":833333.0,"shares_owned_after_display":"833,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000771856","name":"CHAMPIONS ONCOLOGY, INC.","url":"/issuer/0000771856","role":"Director, Officer (CEO)","n_filings":15,"first_seen":"2013-01-30","last_seen":"2023-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001504443","retrieved_at":"2026-08-27T08:12:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}